Table 1

 Botto-Khoury 2 × 4 table for analysis of gene × environment interactions for GSTM1 genotypes versus current ETS exposure (⩾20 cigarettes)

Outcomes(1) GSTM1+ and ETS−(2) GSTM1+ and ETS+(3) GSTM1− and ETS−(4) GSTM1− and ETS+(5) Expected OR§/departure from expected OR (†‡)
In each cell the prevalence (%) of each outcome is shown with numbers of cases and total in parentheses. Adjusted odds ratio (OR) with 95% confidence intervals, adjusted for age, sex, city, family history of asthma, hay fever, eczema and ETS exposure, are compared with the reference cell (second line of each cell). Column 1 shows the reference group without smoke exposure and without a genetic defect in the respective GST enzyme; column 2 shows the effect of GST deficiency alone; column 3 shows the isolated effect of ETS exposure in children with the intact GST gene, respectively; column 4 shows the values for the combined effect of the respective GST deficiency and concomitant ETS exposure; column 5 shows the expected OR under the assumption of a multiplicative effect, the departure from the effect, and the statistical significance of the departure from the multiplicative model.
*p value <0.05 compared with reference group.
†Departure from expected OR  =  OR in column 4 divided by the expected OR.
‡p value from the test for interaction from logistic regression model.
§Expected OR is the product of the ORs in columns 2 and 3.
Current asthma3.9 (29/735)6.1 (2/33)5.1 (39/758)8.9 (4/45)
1.02.94 (0.61 to 14.05)1.40 (0.85 to 2.30)5.48 (1.62 to 18.55)*4.10/1.34 (p = 0.77)
Wheeze ever19.6 (142/725)24.2 (8/33)23.0 (172/748)31.1 (14/45)
1.01.81 (0.75 to 4.41)1.27 (0.98 to 1.64)2.81 (1.31 to 6.04)*2.30/1.22 (p = 0.71)
Current wheeze6.5 (47/726)9.1 (3/33)8.9 (67/749)17.8 (8/45)
1.02.03 (0.55 to 7.54)1.50 (1.01 to 2.22)*4.74 (1.79 to 12.57)*3.04/1.56 (p = 0.56)
Current cough without cold15.5 (113/727)12.1 (4/33)15.5 (117/753)26.1 (12/46)
1.01.04 (0.34 to 3.18)1.03 (0.78 to 1.37)2.76 (1.23 to 6.17)*1.07/2.58 (p = 0.15)